Researchers from Egypt and Saudi Arabia have developed an innovative progesterone-reishi mushroom composite, published in RSC Advances, that could revolutionize hormone replacement therapy (HRT) and breast cancer treatments. By encapsulating progesterone in Ganoderma lucidum (reishi), the team achieved 98.1% loading efficiency and sustained release of 88.25% over 48 hours—far outperforming free progesterone's rapid 2-4 hour dissolution.

The nation’s first regulated psilocybin market shows promise but faces hurdles in accessibility and cost. In 2020, Oregon became the...

Researchers at the Instituto Leônidas & Maria Deane – Fiocruz Amazônia have tested a new biocontrol strategy against Anopheles aquasalis...

Researchers examined four wild mushroom species from Kargil and found them packed with essential nutrients, antioxidants, and bioactive compounds, positioning them as promising candidates for dietary supplements and functional foods.

Compass Pathways has become the first company to publish Phase 3 data for a classical psychedelic. Its synthetic psilocybin candidate,...